FDA Releases Update of Test Substitution Tool Identifying Validated Supply Alternatives for SARS-CoV-2 Testing
The FDA recently updated its interactive tool designed to assist in identifying COVID-19 testing supply alternatives.
New Meta-analysis Reveals Significant Weaknesses in Evidence Base for Point-of-Care SARS-CoV-2 Serology Tests
New research casts doubt on the evidence that SARS-CoV-2 serology testing yields useful data.